Latest news
Loading news…
Eyetech Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring). New York, United States Founded 1997 251-500 employees For Profit
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye.
Eyetech Pharmaceuticals was acquired by Bausch Health in 2012.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Delisted
- Ticker
- EYET
- Exchange
- NASDAQ
- IPO date
- Jan 30, 2004
- Raised at IPO
- $137M
- Valuation at IPO
- $809M
- Delisted
- Nov 14, 2005
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 5
- Active products
- 5
- IT spend
- $9M
Company Info
- Founded
- 1997
- Employees
- 251-500
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 4
- News articles
- 14
- HQ
- New York, United States
- Region
- Greater New York Area, East Coast, Northeastern US
- Exit date
- Jan 30, 2004
- Closed
- Jan 1, 2021
Signals & Scores
- Heat score
- Low
- Trend (7d)
- 2
- Trend (30d)
- -0.3
- Trend (90d)
- -0.1
Key People at Eyetech Pharmaceuticals
Chairman
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Eyetech Pharmaceuticals
Loading news…
FAQs about Eyetech Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.